BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2644050)

  • 1. Train-of-four ratio after antagonism of atracurium with edrophonium: influence of different priming doses of edrophonium.
    Naguib M
    Can J Anaesth; 1989 Jan; 36(1):25-9. PubMed ID: 2644050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming with anti-cholinesterases--the effect of different priming doses of edrophonium.
    Naguib M; Abdulatif M
    Can J Anaesth; 1988 Jan; 35(1):53-7. PubMed ID: 3349555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edrophonium priming for antagonism of atracurium neuromuscular blockade.
    Szalados JE; Donati F; Bevan DR
    Can J Anaesth; 1990 Mar; 37(2):197-201. PubMed ID: 2311149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tactile evaluation of train-of-four count as an indicator of reliability of antagonism of vecuronium- or atracurium-induced neuromuscular blockade.
    Kopman AF
    Anesthesiology; 1991 Oct; 75(4):588-93. PubMed ID: 1681762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.
    Naguib M; Abdulatif M
    Can J Anaesth; 1991 Sep; 38(6):722-7. PubMed ID: 1655299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming reversal of profound atracurium blockade by edrophonium and neostigmine.
    Liu CH; Lin IS; Liu CG; Peng TH; Yeh YJ; Chuu LJ; Lin SY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 May; 11(5):257-64. PubMed ID: 7602663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming with anti-cholinesterases--the effect of different combinations of anti-cholinesterases and different priming intervals.
    Naguib M; Abdulatif M
    Can J Anaesth; 1988 Jan; 35(1):47-52. PubMed ID: 3349554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE; Donati F; Bevan DR
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The maximum depth of an atracurium neuromuscular block antagonized by edrophonium to effect adequate recovery.
    Beemer GH; Goonetilleke PH; Bjorksten AR
    Anesthesiology; 1995 Apr; 82(4):852-8. PubMed ID: 7717555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neostigmine and edrophonium as antagonists of atracurium and pancuronium.
    Sanfilippo M; Vilardi V; Fierro G; Rosa G; Pelaia P; Gasparetto A
    Acta Anaesthesiol Scand; 1988 Aug; 32(6):437-40. PubMed ID: 2845694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Priming" with neostigmine: failure to accelerate reversal of single twitch and train-of-four responses.
    Donati F; Smith CE; Wiesel S; Bevan DR
    Can J Anaesth; 1989 Jan; 36(1):30-4. PubMed ID: 2644051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium.
    Jones RM; Pearce AC; Williams JP
    Br J Anaesth; 1984 May; 56(5):453-7. PubMed ID: 6326785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
    Donati F; Smith CE; Bevan DR
    Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edrophonium antagonism of atracurium during enflurane anaesthesia.
    Gill SS; Bevan DR; Donati F
    Br J Anaesth; 1990 Mar; 64(3):300-5. PubMed ID: 2328178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
    Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
    Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of intense atracurium-induced neuromuscular block in children.
    Gwinnutt CL; Walker RW; Meakin G
    Br J Anaesth; 1991 Jul; 67(1):13-6. PubMed ID: 1859751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edrophonium antagonism of cisatracurium-induced neuromuscular block: dose requirements in children and adults.
    Abdulatif M; El-Sanabary M
    Anaesth Intensive Care; 2001 Aug; 29(4):364-70. PubMed ID: 11512646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.